Open Label Study of Long Term Safety Evaluation of Alirocumab

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 986 participants.

Also called NCT01954394

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 986 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01954394
  • EudraCT 2013-002572-40
Other papers using this trial's data
  • Alirocumab dosing patterns during 40 months of open-label treatment in patients with heterozygous familial hypercholesterolemia Journal of clinical lipidology, 2018 DOI, PubMed 30287210
  • Long-term safety and efficacy of alirocumab in patients with heterozygous familial hypercholesterolemia: An open-label extension of the ODYSSEY program Atherosclerosis, 2018-11 DOI, PubMed 30293878

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Austria, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Mexico, Netherlands, Norway, Portugal, Romania, Russia, South Africa, Spain, Sweden, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01954394. Allocation not applicable; no masking; primary purpose treatment. Start 2013-12-17 (registry gives no type); primary completion 2017-06-30 (actual). Results posted on 2018-07-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Open Label Study of Long Term Safety Evaluation of Alirocumab
Acronym
ODYSSEY OLE
Condition
Hypercholesterolemia
Intervention (Drug)
Alirocumab
Intervention (Drug)
Lipid-Modifying Therapy (LMT)
Lead sponsor
Sanofi (class: industry)
Collaborator
Regeneron Pharmaceuticals (class: industry)

Record details

Record id
cardio:ct-nct01954394
Content hash
80723e09063fd1874a71a71b0d11caace88446c2d36fe6f6f01caf752d204388